Plain-English translation of NCT06541340 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new strategy for preparing patients with pancreatic head cancer for surgery. Specifically, it compares two different approaches to biliary drainage — a procedure that helps remove excess bile buildup before the cancer surgery happens. The goal is to figure out which approach leads to fewer complications and better long-term outcomes.
When pancreatic head cancer causes severe jaundice (yellowing of the skin), doctors typically drain the bile before surgery to help patients recover better. However, there's disagreement about the best way to do this — whether to measure bilirubin (a waste product) or prealbumin (a protein) to decide when the patient is ready for surgery. This trial will provide clear evidence about which approach works best.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups. One group will use the traditional approach (measuring bilirubin to decide when you're ready for surgery), and the other will use the new approach (measuring prealbumin instead). Both groups will receive endoscopic biliary drainage before surgery. The study will track your recovery, any complications after surgery, and your long-term health outcomes.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
China